Checkpoint Capital L.P.
- SEC CIK
- 0001977548
- Latest filing
- Aug 14, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Checkpoint Capital L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −174,769−100.0% | Sold out | Holders |
| Q4 2024 | 174,769 | $14.8M | 7.5% | −34,863−16.6% | Reduced | Holders |
| Q3 2024 | 209,632 | $18.8M | 9.3% | −81,140−27.9% | Reduced | Holders |
| Q2 2024 | 290,772 | $23.4M | 14.1% | +158,335+119.6% | Added | Holders |
| Q1 2024 | 132,437 | $10.6M | 7.1% | −22,909−14.7% | Reduced | Holders |
| Q4 2023 | 155,346 | $12.4M | 8.6% | – | No prior filing | Holders |